Table.
Demographic and clinical characteristics of study participants
0–4 years of age |
5–11 years of age |
||||||||
---|---|---|---|---|---|---|---|---|---|
Number of children | Infections | Hospitalisations | Deaths | Number of children | Infections | Hospitalisations | Deaths | ||
Total | 481 528 | 127 211 | 691 | 5 | 887 193 | 257 592 | 426 | 10 | |
Unvaccinated | 430 698 | 584 707 | |||||||
Before authorisation | 90 221 | 509 | 4 | 76 619 | 176 | 4 | |||
After authorisation | 27 449 | 161 | 1 | 116 108 | 141 | 5 | |||
Vaccinated | 50 830 | 302 486 | |||||||
Before authorisation | 7447 | 15 | 0 | 22 381 | 57 | 0 | |||
After authorisation | 2094 | 6 | 0 | 42 484 | 52 | 1 | |||
One dose only | 11 235 | 39 261 | |||||||
Before first dose | 2083 | 6 | 0 | 5372 | 9 | 0 | |||
After first dose | 159 | 0 | 0 | 3319 | 3 | 0 | |||
Two doses only | 28 066 | 216 330 | |||||||
Before second dose | 4913 | 8 | 0 | 28 550 | 56 | 0 | |||
After second dose | 341 | 1 | 0 | 18 132 | 26 | 1 | |||
Three doses | 11 529 | 46 895 | |||||||
Before third dose | 1966 | 6 | 0 | 8584 | 14 | 0 | |||
After third dose | 79 | 0 | 0 | 908 | 1 | 0 | |||
Sex | |||||||||
Female | 235 838 | 60 859 | 308 | 4 | 434 917 | 125 552 | 199 | 4 | |
Male | 245 690 | 66 352 | 383 | 1 | 452 276 | 132 040 | 227 | 6 | |
Race and ethnicity | |||||||||
Black or Hispanic | 206 120 | 49 191 | 333 | 1 | 369 667 | 98 221 | 191 | 4 | |
Other | 275 408 | 78 020 | 358 | 4 | 517 526 | 159 371 | 235 | 6 | |
Geographical region | |||||||||
Coastal plain | 139 930 | 34 034 | 205 | 0 | 250 132 | 69 609 | 117 | 1 | |
Piedmont | 299 124 | 83 002 | 441 | 5 | 557 837 | 165 417 | 264 | 8 | |
Mountain | 42 474 | 10 175 | 45 | 0 | 79 224 | 22 566 | 45 | 1 | |
County vaccination | |||||||||
<62% | 165 702 | 41 659 | 270 | 1 | 299 029 | 83 985 | 152 | 1 | |
62–75% | 143 831 | 37 474 | 234 | 1 | 274 978 | 78 769 | 149 | 5 | |
>75% | 171 995 | 48 078 | 187 | 3 | 313 186 | 94 838 | 125 | 4 |